Copy Number
The putative cancer-associated PDGs driven by SCNAs in each cancer type were identified by four criteria: 1) located in a peak region of a significantly recurrent focal SNCA locus estimated by the genomic identification of significant targets in cancer (GISTIC2) algorithm, (q≤0.25); 2) altered with high frequency and large amplitude (G-score ≥0.1); 3) mRNA reliably detected in at least 10% of tumor specimens in the given cancer type (90th percentile of FPKM value ≥1); and 4) mRNA significantly and positively correlated with copy numbers (Pearson P-value less than 0.001).
| Showing page 96 |
first page | previous page | next page | last page |
| Overall_Gscore | No. of Cancer Types | ||||
| HGNC Symbol | Ensembl Gene ID | Amplification | Deletion | Amplification | Deletion |
| OR5AU1 | ENSG00000169327 | 0.00 | 0.00 | 0 | 0 |
| UMOD | ENSG00000169344 | 0.00 | 0.00 | 0 | 0 |
| GP2 | ENSG00000169347 | 0.00 | 0.00 | 0 | 0 |
| SLC33A1 | ENSG00000169359 | 0.00 | 0.00 | 0 | 0 |
| RNASE2 | ENSG00000169385 | 0.00 | 0.00 | 0 | 0 |
| ELSPBP1 | ENSG00000169393 | 0.00 | 0.00 | 0 | 0 |
| RNASE3 | ENSG00000169397 | 0.00 | 0.00 | 0 | 0 |
| RNASE6 | ENSG00000169413 | 0.00 | 0.00 | 0 | 0 |
| NPR1 | ENSG00000169418 | 0.00 | 0.00 | 0 | 0 |
| KCNK9 | ENSG00000169427 | 0.00 | 0.00 | 0 | 0 |
| CXCL8 | ENSG00000169429 | 0.00 | 0.00 | 0 | 0 |
| CD52 | ENSG00000169442 | 0.00 | 0.40 | 0 | 3 |
| OR4K14 | ENSG00000169484 | 0.00 | 0.00 | 0 | 0 |
| OR4K15 | ENSG00000169488 | 0.00 | 0.00 | 0 | 0 |
| GPR183 | ENSG00000169508 | 0.00 | 0.00 | 0 | 0 |
| MUC15 | ENSG00000169550 | 0.00 | 0.00 | 0 | 0 |
| GJB1 | ENSG00000169562 | 0.00 | 0.00 | 0 | 0 |
| VPREB1 | ENSG00000169575 | 0.00 | 0.00 | 0 | 0 |
| GKN1 | ENSG00000169605 | 0.00 | 0.00 | 0 | 0 |
| PROKR1 | ENSG00000169618 | 0.00 | 0.00 | 0 | 0 |
|
Showing page 96 |
first page | previous page | next page | last page |
Copyright © 2020 University of Pennsylvania. All Rights Reserved.